CYNTHIA BOSQUILLON cynthia.bosquillon@nottingham.ac.uk
Assistant Professor
A comparison of drug transport in pulmonary absorption models: isolated perfused rat lungs, respiratory epithelial cell lines and primary cell culture
Bosquillon, Cynthia; Madlova, Michaela; Patel, Nilesh; Clear, Nicola; Forbes, Ben
Authors
Michaela Madlova
Nilesh Patel
Nicola Clear
Ben Forbes
Abstract
Purpose
To evaluate the ability of human airway epithelial cell layers and a simple rat isolated perfused lung (IPL) model to predict pulmonary drug absorption in rats in vivo.
Method
The permeability of seven compounds selected to possess a range of lipophilicity was measured in two airway cell lines (Calu-3 and 16HBE14o-), in normal human bronchial epithelial (NHBE) cells and using a simple isolated perfused lungs (IPL) technique. Data from the cell layers and ex vivo lungs were compared to published absorption rates from rat lungs measured in vivo.
Results
A strong relationship was observed between the logarithm of the in vivo absorption half-life and the absorption half-life in the IPL (r = 0.97; excluding formoterol). Good log-linear relationships were also found between the apparent first-order absorption rate in vivo and cell layer permeability with correlation coefficients of 0.92, 0.93, 0.91 in Calu-3, 16HBE14o- and NHBE cells, respectively.
Conclusion
The simple IPL technique provided a good prediction of drug absorption from the lungs, making it a useful method for empirical screening of drug absorption in the lungs. Permeability measurements were similar in all the respiratory epithelial cell models evaluated, with Calu-3 having the advantage for routine permeability screening purposes of being readily availability, robust and easy to culture.
Citation
Bosquillon, C., Madlova, M., Patel, N., Clear, N., & Forbes, B. (in press). A comparison of drug transport in pulmonary absorption models: isolated perfused rat lungs, respiratory epithelial cell lines and primary cell culture. Pharmaceutical Research, 34(12), https://doi.org/10.1007/s11095-017-2251-y
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 24, 2017 |
Online Publication Date | Sep 18, 2017 |
Deposit Date | Sep 25, 2017 |
Publicly Available Date | Sep 25, 2017 |
Journal | Pharmaceutical Research |
Print ISSN | 0724-8741 |
Electronic ISSN | 1573-904X |
Publisher | American Association of Pharmaceutical Scientists |
Peer Reviewed | Peer Reviewed |
Volume | 34 |
Issue | 12 |
DOI | https://doi.org/10.1007/s11095-017-2251-y |
Keywords | 16HBE14o-; biopharmaceutics; calu-3; inhalation; isolated perfused lungs (IPL); NHBE permeability; pulmonary |
Public URL | https://nottingham-repository.worktribe.com/output/883351 |
Publisher URL | https://link.springer.com/article/10.1007/s11095-017-2251-y |
Contract Date | Sep 25, 2017 |
Files
2017 Pharm Res (Bosquillon).pdf
(860 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung
(2019)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search